EpiEndo Pharmaceuticals welcomes Maria Bech as new CEO

– ICELAND, Reykjavik –  EpiEndo Pharmaceuticals, a privately-held biopharmaceutical company currently developing a next-generation therapeutic platform for the treatment of inflammatory disorders through addressing underlying causal pathways of disease, today announced the appointment of Maria Bech as CEO, effective immediately, succeeding Dr.…